Carey Macrury
Stock Analyst at Canaccord Genuity
(1.32)
# 3,329
Out of 4,754 analysts
17
Total ratings
46.15%
Success rate
-3.25%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Carey Macrury
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IAG IAMGOLD | Upgrades: Buy | $7.75 → $11 | $5.54 | +89.53% | 2 | Oct 22, 2024 | |
| APTO Aptose Biosciences | Maintains: Buy | $195 → $120 | $2.85 | +4,110.53% | 1 | Mar 27, 2023 | |
| NEM Newmont | Upgrades: Buy | $53 → $55 | $42.36 | +29.84% | 6 | Mar 14, 2023 | |
| RGLD Royal Gold | Upgrades: Buy | $151 → $140 | $147.56 | -5.12% | 2 | Jun 13, 2022 | |
| CGAU Centerra Gold | Downgrades: Speculative Buy | $18 → $15 | $5.69 | +154.83% | 1 | Apr 21, 2021 | |
| AEM Agnico Eagle Mines | Maintains: Buy | $115 → $110 | $95.93 | +14.67% | 5 | Feb 23, 2021 |
IAMGOLD
Oct 22, 2024
Upgrades: Buy
Price Target: $7.75 → $11
Current: $5.54
Upside: +89.53%
Aptose Biosciences
Mar 27, 2023
Maintains: Buy
Price Target: $195 → $120
Current: $2.85
Upside: +4,110.53%
Newmont
Mar 14, 2023
Upgrades: Buy
Price Target: $53 → $55
Current: $42.36
Upside: +29.84%
Royal Gold
Jun 13, 2022
Upgrades: Buy
Price Target: $151 → $140
Current: $147.56
Upside: -5.12%
Centerra Gold
Apr 21, 2021
Downgrades: Speculative Buy
Price Target: $18 → $15
Current: $5.69
Upside: +154.83%
Agnico Eagle Mines
Feb 23, 2021
Maintains: Buy
Price Target: $115 → $110
Current: $95.93
Upside: +14.67%